Abstract
Oral candidiasis is the most common opportunistic fungal infection in individuals infected with the human immunodeficiency virus (HIV) and is considered an independent predictor of immunodeficiency in patients with acquired immunodeficiency syndrome (AIDS) 1, 2 . In addition, esophageal candidiasis is considered to be an AIDS-defining condition 3 . Clinical features of oral thrush and esophageal candidiasis comprise white oral patches; oral ulcers and painful swallowing may also be observed 4 .
The cluster of differentiation 4+ (CD4+) T-lymphocyte count in peripheral blood is an important marker of the patient's immune status and of their susceptibility to the development of opportunistic infections, such as oropharyngeal candidiasis 5 . Although Candida albicans is the most frequently-isolated species related to oral opportunistic infections, an increase in the frequency of oral infections caused by non-albicans species such as Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei and Candida dubliniensis has been observed in the last decade 1, 2 .
Identification of the species is important for epidemiological reasons and for treatment purposes to ensure a better prognosis since some species present reduced susceptibility to azoles 2, 4, 5 . Therefore, the present study aimed to investigate the correlation between the presence of oral lesions caused by Candida spp. with the level of CD4+ T-lymphocyte in HIV-positive patients, and to determine the distribution and antifungal susceptibility of Candida species isolated from the oral cavities of HIV-positive patients, with and without lesions.
A total of 60 seropositive HIV patients [diagnosed by enzyme-linked immunosorbent assay (ELISA) and Westernblot] admitted at the University Hospital Maria Aparecida Pedrossian (UH-MAP), Mato Grosso do Sul, Brazil, were included in this study. The participants were recruited from December 2014 to July 2015 and data such as age, gender, hospitalization, the presence of oral lesions and CD4+ T-lymphocyte counts were obtained from their medical records. To compare the possible associations between the variables under study, the chi-square test and Fisher's exact test were applied, as appropriate. Statistical analyses were performed using the program Minitab, version 16 (Minitab Inc., State College, PA, USA).
Samples collected via oral swab were inoculated in Sabouraud-dextrose broth (Himedia, India). After 24h at 35ºC, Candida glabrata species-specificity primers; CALF + CALR and CDUF + CDUR: species-specificity primers pairs for Candida albicans and Candida dubliniensis identification, respectively; S1F and S1R: primer sequences used for identification of species of Candida parapsilosis complex; UNI-5.8S, GLA-f, NIV-f and BRA-f: primer sequences used for identification of species of Candida glabrata complex.
the samples were plated in Sabouraud-dextrose agar (Himedia, India) for 24h at 35ºC. Suggestive colonies of Candida spp. were then plated in CHROMagar Candida (Difco, USA) for 48h at 35°C for presumptive identification. For genotypic identification, genomic deoxyribonucleic acid (DNA) was extracted and purified using the YeaStar™ DNA Extraction Kit (Zymo Research, USA) in accordance with the manufacturer's instructions.
For the initial differentiation among Candida species, multiplex polymerase chain reaction technique (PCRm) was performed as described by Li et al. 6 . For the differentiation between C. albicans and C. dubliniensis, C. parapsilosis complex and C. glabrata complex, the following techniques were performed respectively: duplex PCR 7 , PCR followed by restriction fragment length polymorphism 8 and PCRm 9 . All the primers used in the PCR techniques are described in Table 1 .
The minimum inhibitory concentrations (MIC) of the antifungal agents fluconazole (Pfizer, Brazil), itraconazole (Sigma, USA), voriconazole (Sigma, USA) and amphotericin B (Sigma, USA) were determined using the broth microdilution method. ATCC strains (C. krusei ATCC 6258 and C. parapsilosis ATCC 22019) were used as quality control. The MIC results were interpreted according to the Clinical and Laboratory Standards Institute breakpoints 10 .
Ethical considerations
The study protocol was approved by the Research Ethics Committee of the Federal University of Mato Grosso do Sul. All patients who agreed to participate in this study signed a consent form. To our knowledge, this is the first study on oral candidiasis in the State of Mato Grosso do Sul, Midwest Region, Brazil.
The patients' ages ranged from 24 to 76 years, with a mean of 42.3 years, and with male predominance (75.8%). Similar to previous studies 2, 4 , the most affected age group was 24 to 40 years, which is the most sexually active population. The prevalence of male HIV-positive patients related to oropharyngeal candidiasis had been reported previously 4 . Patients' clinical, demographic and hospital admission data are summarized in Table 2 .
According to a previous study, variations in the clinical aspects of oral candidiasis have been associated with the progression of HIV infection as the CD4+ T-lymphocyte counts decrease 11 . In our study, 16 (24.2%) out of 66 patients presented oral lesions with the following features: pseudomembranous (8, 50%), erythematous (3, 18.7%), chronic multifocal (3, 18.7%) and angular cheilitis (2, 12.5%). Candidiasis with pseudomembranous lesion as observed in most cases in our study is consistent with the findings of other authors 2, 11 . There was no significant correlation between species and type of host-parasite relationship and between species and clinical presentation of oral lesions (Table 2) . However, the number of cases was small and these results should be reevaluated in a larger number of patients.
Among the 16 individuals with oral lesions, 15 (93.7%) had CD4+ T-lymphocyte counts ≤ 200 cells/μL (p < 0.05) showing that oral candidiasis is a highly predictive marker of immunosuppression, as previously reported 5, 11 . Despite having no apparent lesion, 32 (48.5%) patients had Candida spp. isolated from their oral cavities, demonstrating colonization. Previous studies have shown that in Brazil, the rate of colonization has ranged from 50.4% to 62.0% in this group of patients 1, 12, 13 . The use of antibiotics and oral prostheses are some of the predisposing factors for oral colonization by Candida spp. 1 .
Among the 45 Candida spp. isolates, C. albicans (30, 66.7%) was prevalent in relation to non-albicans species (15, 33.3%), confirming the results of previous studies 1, 2, 4, [13] [14] [15] . The following non-albicans species were identified: C. tropicalis (6, 13.3%), C. krusei (4, 8.9%), C. parapsilosis sensu stricto (2, 4.4%), C. glabrata sensu stricto (2, 4.4%) and C. dubliniensis (1, 2.2%).
Studies carried out in São Paulo showed that among nonalbicans isolates, C. glabrata was the most frequently-isolated species from the saliva of HIV-infected patients without clinical lesions 13 while in other cities of the Southeastern region of Brazil such as São José dos Campos-SP and Uberlândia-MG, the most commonly isolated non-albicans species from oropharyngeal candidiasis were C. tropicalis 15 and C. parapsilosis 1 , respectively. This fact shows that the distribution of non-albicans isolates from the oral cavity varies from region to region
To assist the clinician in making therapeutic decisions and to optimize treatment, clinical microbiologists should identify Candida to the species level, especially in HIV-positive patients, in whom non-albicans species are being increasingly recognized to cause serious infections 4 .
With the advent of molecular biology techniques, it was possible to differentiate species such as C. albicans and C. dubliniensis, C. parapsilosis complex and C. glabrata complex. Although C. dubliniensis has been associated with oral candidiasis in HIV infected patients worldwide, in our study, as in other Brazilian studies 12, 13 , the prevalence rate of this species was considered low.
The in vitro susceptibility profiles of the Candida species studied are shown in Table 3 . Candida albicans, C. tropicalis, C. krusei, C. parapsilosis sensu stricto and C. dubliniensis presented susceptibility to all antifungal agents tested. Two isolates of C. glabrata sensu stricto showed dose-dependent susceptibility to fluconazole and one dose-dependent susceptibility to itraconazole.
The pattern of antifungal resistance also varies with geographical region. In contrast to previous studies carried out in other Brazilian regions 12, 14 , non-albicans species isolated from patients living in Mato Grosso do Sul State, showed a high susceptibility to the antifungal agents tested.
In conclusion, individuals with high levels of immunosuppression are more susceptible to the development of oral candidiasis. The presence of oral lesions caused by Candida spp., mainly of the pseudomembranous form, can act as an indirect marker of immunosuppression in HIV-positive patients.
In addition, Candida spp. are commonly found among HIV-positive patients with and without oral lesions. Although C. albicans is the most frequent species isolated in the oral mucosa, non-albicans isolates represent a relevant percentage of isolates. Despite the good in vitro susceptibility, the lower susceptibility to azoles by non-albicans isolates supports the importance of surveillance studies using susceptibility tests to achieve better results in the pharmacological treatment of oropharyngeal candidiasis.
